These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17878243)

  • 1. GAD antibody in multiplex diabetic pedigrees of Chinese.
    Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
    Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
    [No Abstract]   [Full Text] [Related]  

  • 2. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes: response to Buzzetti et al.
    Kobayashi T; Tanaka S; Shimada A; Maruyama T
    Diabetes Care; 2007 Nov; 30(11):e126; author reply e127. PubMed ID: 17965310
    [No Abstract]   [Full Text] [Related]  

  • 3. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
    Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
    Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
    Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
    Exp Clin Endocrinol Diabetes; 1995; 103(2):123-5. PubMed ID: 7553076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
    Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
    Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.
    Molven A; Ringdal M; Nordbø AM; Raeder H; Støy J; Lipkind GM; Steiner DF; Philipson LH; Bergmann I; Aarskog D; Undlien DE; Joner G; Søvik O; ; Bell GI; Njølstad PR
    Diabetes; 2008 Apr; 57(4):1131-5. PubMed ID: 18192540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and prevention of type I diabetes.
    Eisenbarth GS; Gianani R; Pugliese A; Verge CF; Pietropaolo M
    Transplant Proc; 1994 Apr; 26(2):361-2. PubMed ID: 8171463
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.
    Hussain MJ; Peakman M; Gallati H; Lo SS; Hawa M; Viberti GC; Watkins PJ; Leslie RD; Vergani D
    Diabetologia; 1996 Jan; 39(1):60-9. PubMed ID: 8720604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Latent autoimmune diabetes mellitus].
    St Martin
    Dtsch Med Wochenschr; 1999 Feb; 124(5):135. PubMed ID: 10076556
    [No Abstract]   [Full Text] [Related]  

  • 11. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes.
    Nicoletti F; Conget I; Di Marco R; Speciale AM; Morìnigo R; Bendtzen K; Gomis R
    Diabetologia; 2001 Mar; 44(3):309-11. PubMed ID: 11317661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical relevance of anti-GAD antibody in IDDM and NIDDM].
    Takahashi K; Satoh J; Toyota T
    Nihon Rinsho; 1997 Nov; 55 Suppl():319-23. PubMed ID: 9434487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical characteristics and classification of 2128 outpatients with diabetes].
    Qi HY; Zhou ZG; Li X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):184-6. PubMed ID: 16145908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
    Atlan-Gepner C; Vialettes B
    Diabetes Metab; 1999 Jun; 25(2):177-9. PubMed ID: 10443330
    [No Abstract]   [Full Text] [Related]  

  • 16. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 17. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
    Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GAD antibodies, GAD65 antibody].
    Yamanouchi T
    Nihon Rinsho; 1999 Dec; 57 Suppl():372-5. PubMed ID: 10778142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.